A Plus Biotechnology Co., Ltd. (TPE:6918)
Taiwan
· Delayed Price · Currency is TWD 84.00
+2.20 (2.69%)
At close: Mar 6, 2026
A Plus Biotechnology Market Cap
A Plus Biotechnology has a market cap or net worth of 2.78 billion as of March 9, 2026. Its market cap has decreased by -4.28% in one year.
Market Cap
2.78B
Enterprise Value
2.29B
Revenue
825.52M
Ranking
n/a
PE Ratio
15.15
Stock Price
84.00
Market Cap Chart
Since January 6, 2023, A Plus Biotechnology's market cap has increased from 1.52B to 2.78B, an increase of 82.26%. That is a compound annual growth rate of 20.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 2.78B | -6.06% |
| Dec 31, 2025 | 2.96B | 20.95% |
| Dec 31, 2024 | 2.44B | 77.04% |
| Dec 29, 2023 | 1.38B | -9.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medimaging Integrated Solution | 3.09B |
| WeLeader Biomedical | 3.19B |
| Applied BioCode | 2.43B |
| Dynamic Medical Technologies | 2.37B |
| Wellell | 2.29B |
| Diamond Biotechnology | 1.99B |
| OK Biotech | 1.98B |
| Bonraybio | 4.27B |